Balanitis |
Balanitis can result from a range of etiologies. One etiological category is infectious agents which include candida, anaerobic or aerobic bacterial infections, human papillomavirus, herpes simplex, gardnerella vaginalis, treponema pallidum which causes syphilis and borrelia burgdorferi which causes Lyme disease. There are also forms of balanitis that are associated with certain diseases such as circinate balanitis which is associated with adults who have Reiters syndrome and balanitis xerotica obliterans (BXO) in patients with lichen sclerosis. Balanitis is also seen in individuals with Bowen's disease, psoriasis, leukoplakia and seborrheic dermatitis. Poor hygiene is also a major contributor to the etiology of balanitis as well as trauma, contact dermatitis, allergies and fixed drug eruptions from drugs such as tetracyclines, salicylates and phenacetin. Various tests that can be obtained to confirm the diagnosis include a serum glucose test, a culture of the discharge, a syphilis serology test, a potassium hydroxide test for candida, HIV and human papilloma virus titers in certain severe cases, and an ultrasound or bladder scan for the investigation of urinary obstruction. In adults with balanitis, diabetes is the most common underlying medical condition. This must be taken into consideration when investigating the development of balanitis in an otherwise healthy individual. Poorly controlled blood glucose is associated with increased occurrence of candidal species beneath the prepuce, which can lead to balanitis. It has been shown that the ingestion of yogurt containing lactobacillus decreases candidal colonization in humans. The initial management of balanitis should involve careful evaluation for the presence of an immunocompromising medical condition such as diabetes or an HIV infection. Treatment includes the use of topical antifungal agents such as a topical imidazole, either 1% clotrimazole or 2% miconazole applied twice a day for one to three weeks. For severe symptoms patients can use oral fluconazole or 1% hydrocortisone cream as an adjunct to topical imidazole. In addition, in cases of resistance or allergy to imidazoles, nystatin cream may be used.
|
2/27/2018MACRA/MIPS Update
10/12/2017Foundation for Osteopathic Dermatology
7/6/2016Disclosure to members regarding CME activities
4/3/2014The Burning Truth
12/19/2013Osteopathic Training Statement
10/9/2018 » 10/13/2018
2018 AOCD Fall Current Concepts in Dermatology Meeting
4/9/2019 » 4/13/2019
2019 AOCD Spring Current Concepts in Dermatology Meeting
9/24/2019 » 9/28/2019
2019 AOCD Fall Current Concepts in Dermatology
2/19/2020 » 2/22/2020
2020 AOCD Spring Current Concepts in Dermatology
2/24/2021 » 2/27/2021
2021 AOCD Spring Current Concepts in Dermatology